Synthesis & Characterization of a Tuberculosis Vaccine

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 1R43AI056880-01A1
Agency Tracking Number: AI056880
Amount: $133,000.00
Phase: Phase I
Program: SBIR
Awards Year: 2004
Solitcitation Year: 2004
Solitcitation Topic Code: N/A
Solitcitation Number: PHS2004-2
Small Business Information
ANCORA PHARMACEUTICALS
ANCORA PHARMACEUTICALS, 700 HURON AVE, #18K, CAMBRIDGE, MA, 02138
Duns: N/A
Hubzone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 OBADIH Plante
 (781) 395-7700
 OPLANTE@ANCORAPHARMA.COM
Business Contact
 JOHN PENA
Phone: (617) 354-0863
Email: JPENA@ANCORAPHARMA.COM
Research Institution
N/A
Abstract
DESCRIPTION (provided by applicant): Tuberculosis (TB) has plagued mankind for millennia. While several drugs and vaccine strategies have been developed to counter the TB, it remains a major infectious cause of morbidity and mortality worldwide. 1.Thoug

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government